welcome to oneEDSvoice
- a positively charged Ehlers Danlos Syndrome community.- join today!
- login
The Evidence-Based Rationale for PhysicalTherapy Treatment of Children, Adolescents,and Adults Diagnosed With Joint HypermobilitySyndrome/Hypermobile Ehlers Danlos Syndrome
source: American Journal of Medical Genetics
year: 2017
authors: Raoul H.H. Engelbert, Birgit Juul-Kristensen, Verity Pacey, Inge de Wandele, Sandy Smeenk, Nicoleta Woinarosky, Stephanie Sabo, Mark C. Scheper, Leslie Russek, Jane V. Simmonds
summary/abstract:New insights into the phenotype of Joint Hypermobility Syndrome (JHS) and Ehlers-Danlos Syndrome-hypermobile type (hEDS) have raised many issues in relation to classification, diagnosis, assessment, and treatment. Within the multidisciplinary team, physical therapy plays a central role in management of individuals with hypermobility related disorders. However, many physical therapists are not familiar with the diagnostic criteria, prevalence, common clinical presentation, and management. This guideline aims to provide practitioners with the state of the art regarding the assessment and management of children, adolescents, and adults with JHS/hEDS. Due to the complexity of the symptoms in the profile of JHS/hEDS, the International Classification of Functioning, Disability and Health (ICF) is adopted as a central framework whereby the umbrella term of disability is used to encompass functions, activities and participation, as well as environmental and personal factors. The current evidence-based literature regarding the management of JHS/hEDS is limited in size and quality and there is insufficient research exploring the clinical outcomes of a number of interventions. Multicenter randomized controlled trials are warranted to assess the clinical and cost-effectiveness of interventions for children and adults. Until further multicenter trials are conducted, clinical decision-making should be based on theoretical and the current limited research evidence. For all individuals diagnosed with JHS/hEDS, international consensus and combined efforts to identify risk profiles would create a better understanding of the pathological mechanisms and the potential for optimizing health care for affected individuals.
DOI: 10.1002/ajmg.c.31545read more full text source
expertly curated content related to this topic
-
Allele-specific siRNA Knockdown as a Personalized Treatment Strategy for Vascular Ehlers-Danlos Syndrome in Human Fi...The vascular type of the Ehlers-Danlos s...
-
hEDS v. HSD: what’s in a label, Dr. Brad TinkleThere has been a major revisio...
-
Ehlers Danlos Syndrome (Ash)Information on Ehlers-Danlos Syndrome...
-
It’s Time for an Honest Conversation About Pain ManagementPsoriatic arthritis can be a debilitatin...
-
Heartbroken parents lose their third child to vEDS and now fight for awareness and trainingThe family first lost 16-year-old Charlo...
-
Ehlers-Danlos syndrome (Satumaan)Zebra is the mascot for Ehlers Danlos sy...
-
EDS: It Takes a Village – A Physical Therapist’s Role in an Integrative Approachhttps://www.youtube.com/watch?v=ml3R8Cpt...